Systematic evaluation of combined herbal adjuvant therapy for proliferative diabetic retinopathy

Objective To evaluate the efficacy and safety of combined traditional Chinese medicine in the adjuvant treatment of proliferative diabetic retinopathy (PDR) by Meta-analysis. Methods PubMed, Embase, Web of Science, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang databases were searched by computer. Random controlled clinical trials (RCTS) using traditional Chinese medicine as adjuvant therapy for proliferative diabetic retinopathy were screened, and Stata16.0 software was used to perform meta-analysis on the final included literatures. Results A total of 18 studies involving 1392 patients were included. Meta-analysis showed that the clinical effective rate OR=2.99 (CI: 2.18-4.10, I2 = 42.7%, P<0.05); Visual acuity MD=0.10(CI: 0.06-0.13, I2 = 0%, P<0.05); Fundus efficacy OR=5.47 (CI: 1.33-22.51, I2 = 71.4%, P<0.05); Neovascularisation regression rate OR=8 (CI: 3.83-16.71, I2 = 30.1%, P<0.05); Macular foveal thickness MD=-44.24 (CI: -84.55–3.93, I2 = 95.6%, P<0.05); Absorption of vitreous hemorrhage OR=4.7 (CI: 2.26-9.77, I2 = 0%, P<0.05); Fasting blood glucose MD=-0.23, (CI: -0.38–0.07, I2 = 0%, P<0.05); 2h postprandial blood glucose MD=-0.19 (CI: -0.52-0.14, I2 = 0%, P=0.25). From the results, the combined Chinese medicine adjuvant therapy showed better efficacy than the control group. A total of 69 kinds of traditional Chinese medicine were involved in 18 studies, among which the top four applied frequencies were Panax notoginseng, Rehmannia rehmannii, Astragalus membranaceus and Poria cocos. Most of the medicines were sweet and bitter in taste, the qi tended to be slight cold and cold, and the meridian tropism belongs to the liver meridian. Conclusion The combination of traditional Chinese medicine adjuvant therapy has a good curative effect on PDR patients. However, the relevant clinical trials are few and more high-quality clinical trials are still needed, what’s more the attention should be paid to the exploration of its safety.

[1]  Yujuan Xie,et al.  Herb-drug interactions between Panax notoginseng or its biologically active compounds and therapeutic drugs: A comprehensive pharmacodynamic and pharmacokinetic review. , 2023, Journal of ethnopharmacology.

[2]  Qinghua Qiu,et al.  Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications , 2022, Cells.

[3]  T. Wong,et al.  Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. , 2021, Ophthalmology.

[4]  B. Salehi,et al.  Astragalus species: Insights on its chemical composition toward pharmacological applications , 2020, Phytotherapy research : PTR.

[5]  Xianli Meng,et al.  A review of traditional Chinese medicine on treatment of diabetic retinopathy and involved mechanisms. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  L. Gu,et al.  Astragalus polysaccharide attenuates metabolic memory-triggered ER stress and apoptosis via regulation of miR-204/SIRT1 axis in retinal pigment epithelial cells , 2020, Bioscience reports.

[7]  X. Tong,et al.  Evidence and potential mechanisms of traditional Chinese medicine for the treatment of type 2 diabetes: A systematic review and meta‐analysis , 2019, Diabetes, obesity & metabolism.

[8]  Guo-ming Shen,et al.  [Research advances on astragaloside-IV in treatment of diabetes mellitus and its complications pharmacological effects]. , 2017, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[9]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[10]  G. Hu,et al.  Accumulation of biomass and four triterpenoids in two-stage cultured Poria cocos mycelia and diuretic activity in rats. , 2017, Chinese journal of natural medicines.

[11]  Chun Li,et al.  Traditional uses, botany, phytochemistry, pharmacology and toxicology of Panax notoginseng (Burk.) F.H. Chen: A review. , 2016, Journal of ethnopharmacology.

[12]  Z. Kai,et al.  Biological active ingredients of traditional Chinese herb Astragalus membranaceus on treatment of diabetes: a systematic review. , 2015 .

[13]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[14]  Matthew D. Davis,et al.  Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. , 2003, Ophthalmology.

[15]  S. Rong,et al.  In Different Periods of Diabetic Retinopathy in the Observation of the Curative Effect of Treatment of HuaYuMingMu Decoction and Its Influence on VEGF , 2016 .

[16]  Xiang Ping-pin.  Research progress on traditional Chinese medicine treatment of diabetic retinopathy , 2014 .

[17]  Sun Ruixue.  The effect of Chinese traditional medicine combine with laser on the treatment of new vessels of diabetic retinopathy , 2007 .

[18]  J. R. Scotti,et al.  Available From , 1973 .

[19]  Robert C. Wolpert,et al.  A Review of the , 1985 .